163 related articles for article (PubMed ID: 26513873)
1. Syndecan-1 serves as a marker for the progression of epithelial ovarian carcinoma.
Guo Q; Yang X; Ma Y; Ma L
Eur J Gynaecol Oncol; 2015; 36(5):506-13. PubMed ID: 26513873
[TBL] [Abstract][Full Text] [Related]
2. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase A receptor (trkA): a potential marker in epithelial ovarian cancer.
Tapia V; Gabler F; Muñoz M; Yazigi R; Paredes A; Selman A; Vega M; Romero C
Gynecol Oncol; 2011 Apr; 121(1):13-23. PubMed ID: 21236475
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
[TBL] [Abstract][Full Text] [Related]
5. Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma.
Wang ST; Liu JJ; Wang CZ; Lin B; Hao YY; Wang YF; Gao S; Qi Y; Zhang SL; Iwamori M
Oncol Rep; 2012 Apr; 27(4):1065-71. PubMed ID: 22138668
[TBL] [Abstract][Full Text] [Related]
6. Loss of ITM2A, a novel tumor suppressor of ovarian cancer through G2/M cell cycle arrest, is a poor prognostic factor of epithelial ovarian cancer.
Nguyen TM; Shin IW; Lee TJ; Park J; Kim JH; Park MS; Lee EJ
Gynecol Oncol; 2016 Mar; 140(3):545-53. PubMed ID: 26691219
[TBL] [Abstract][Full Text] [Related]
7. Nedd4L expression is decreased in ovarian epithelial cancer tissues compared to ovarian non-cancer tissue.
Yang Q; Zhao J; Cui M; Gi S; Wang W; Han X
J Obstet Gynaecol Res; 2015 Dec; 41(12):1959-64. PubMed ID: 26554540
[TBL] [Abstract][Full Text] [Related]
8. [Expression of hSef and FGF-2 in epithelial ovarian tumor].
Feng QL; Shi HR; Qiao LJ; Zhao J
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):770-4. PubMed ID: 22335910
[TBL] [Abstract][Full Text] [Related]
9. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
Li T; Xue H; Guo Y; Guo K
Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancer.
Kusumoto T; Kodama J; Seki N; Nakamura K; Hongo A; Hiramatsu Y
Oncol Rep; 2010 Apr; 23(4):917-25. PubMed ID: 20204274
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer.
Zhou S; Tang L; Wang H; Dai J; Zhang J; Shen L; Ng SW; Berkowitz RS
Gynecol Oncol; 2013 Oct; 131(1):69-76. PubMed ID: 23820113
[TBL] [Abstract][Full Text] [Related]
12. CXCL12 expression by healthy and malignant ovarian epithelial cells.
Machelon V; Gaudin F; Camilleri-Broët S; Nasreddine S; Bouchet-Delbos L; Pujade-Lauraine E; Alexandre J; Gladieff L; Arenzana-Seisdedos F; Emilie D; Prévot S; Broët P; Balabanian K
BMC Cancer; 2011 Mar; 11():97. PubMed ID: 21410972
[TBL] [Abstract][Full Text] [Related]
13. Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer.
Xie X; Yang M; Ding Y; Yu L; Chen J
Oncol Rep; 2017 Dec; 38(6):3297-3308. PubMed ID: 29039544
[TBL] [Abstract][Full Text] [Related]
14. Dickkopf-4 is frequently overexpressed in epithelial ovarian carcinoma and promotes tumor invasion.
Wang S; Wei H; Zhang S
BMC Cancer; 2017 Jun; 17(1):455. PubMed ID: 28666421
[TBL] [Abstract][Full Text] [Related]
15. EphA8 is a prognostic marker for epithelial ovarian cancer.
Liu X; Xu Y; Jin Q; Wang W; Zhang S; Wang X; Zhang Y; Xu X; Huang J
Oncotarget; 2016 Apr; 7(15):20801-9. PubMed ID: 26989075
[TBL] [Abstract][Full Text] [Related]
16. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
17. Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer.
Xi C; Ren C; Hu A; Lin J; Yao Q; Wang Y; Gao Z; An X; Liu C
Gynecol Oncol; 2013 Dec; 131(3):764-71. PubMed ID: 23994105
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
Ma Z; Wang X; He J; Xia J; Li Y
PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289
[TBL] [Abstract][Full Text] [Related]
19. Epithelial protein lost in neoplasm-α (EPLIN-α) is a potential prognostic marker for the progression of epithelial ovarian cancer.
Liu R; Martin TA; Jordan NJ; Ruge F; Ye L; Jiang WG
Int J Oncol; 2016 Jun; 48(6):2488-96. PubMed ID: 27035883
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]